DAY ONE SATURDAY

I. OVERVIEW-INTRODUCTION
Moderators: S.H. Caldwell/P.D. Mintz
Modern concepts of normal coagulation
Mureane R. Hoffman, MD, PhD (Duke University)
Mechanisms of Coagulopathy in FHF
Santiago J. Munoz, MD (Jefferson Medical College)
What is the prognostic and therapeutic significance of coagulopathy in FHF?
Andreis T. Blei, MD (Northwestern University)
Mechanisms of Coagulopathy in Cirrhosis
Stephen H. Caldwell, MD (UVA)
What is the prognostic and therapeutic significance of coagulopathy in cirrhosis?
Nathan M. Bass, MD, PhD (UCSF)

II. BLEEDING RISK ASSESSMENT IN LIVER DISEASE
Moderators: A. Sanyal/Hoffman
Routine and Experimental Tests of Clotting
Armando Tripodi, PhD (University of Milan)
Experimental Tests of Clotting
Mark Carr, MD (VCU)
Endothelial Function in Cirrhosis
Samuel S. Lee, MD (University of Calgary)
Renal Failure, Cirrhosis and Coagulation
Pere Gines, MD (University of Barcelona)

III. SPECIFIC BLEEDING DISORDERS IN LIVER DISEASE
Moderators: W Lee/T Lisman
DIC in liver disease
James Trotter, MD (University of Colorado)
Dysfibrinoginemia
Mureane R. Hoffman, MD, PhD (Duke University)

RECEPTION FOLLOWS